Immune Checkpoint Inhibitor Therapy in Hormone Receptor-Positive Breast Cancer.

Int J Mol Sci · 2025 · PMC12733652 · PMID 41465595

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

12%; p = 0.041) and showed a trend towards improved mPFS and OS compared to patients with TMB < 14 mut/Mb [ 19 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.